ADVERTISEMENT
India has a head start in generating digital healthcare data and will soon see a UPI (United Payment Interface) like moment for new products and services built using such data, BVR Subramanyam, CEO, Niti Aayog, said.
Delivering a keynote address at the 11th Asia Pacific MedTech Forum 2025 in Delhi, Subrahmanyam said that while the rest of the world is trying to integrate physical data to digital platforms, India is going the digital way to generate data. “The volume of digital data being generated in India in healthcare is probably unprecedented. That gives us a head start. Others are missing out on the potential of it; they are missing the big picture. We were doing Aadhaar- bank account-mobile phone linkage, and the moment you linked all of that, UPI emerged out of it. Similarly, the range of digital data that is coming out, and the amount of data that is out there, it's just a matter of time before somebody is going to tap into it. That is going to be a major turning point”, Subrahmanyam said.
He also said India will lead low-cost innovation in med-tech due to the inherent price sensitivity of Indian society. “It is a price-sensitive market, let’s be very clear, and it is going to continue to be price-sensitive, not because of income, but because of society’s psyche. Price sensitivity in India is going to drive low-cost innovation, and that’s going to be a major driver of making India a global hub of med-tech innovation. The entire digitalisation process on our large population is going to play a major role”, he explained.
September 2025
2025 is shaping up to be the year of electric car sales. In a first, India’s electric vehicles (EV) industry crossed the sales milestone of 100,000 units in FY25, fuelled by a slew of launches by major players, including Tata Motors, M&M, Ashok Leyland, JSW MG Motor, Hyundai, BMW, and Mercedes-Benz. The issue also looks at the challenges ahead for Tata Sons chairman N. Chandrasekaran in his third term, and India’s possible responses to U.S. president Donald Trump’s 50% tariff on Indian goods. Read these compelling stories in the latest issue of Fortune India.
Subrahmanyam said India’s gradual integration on the medical side with the rest of the world will also attract global med-tech companies to set up research and manufacturing bases in India. The Free Trade Agreements (FTAs) India has signed with countries like Australia, UAE and UK and the ones that are being negotiated with several others, including the EU and Canada, are also turning India into a more attractive destination for med-tech firms, he said. “For a large number of medical technology companies, India is going to be very attractive. And I am not looking at medical devices as a vertical. I am looking at it horisontally. This is happening in semiconductor space, manufacturing space, all of that put together creates an ecosystem in India to become a hub of medical device manufacturing”, he said.
According to Subrahmanyam, India is already a huge healthcare market, and there is going to be a huge medical device market as well. “The Indian medical device market will be three or four times bigger than its current size in the next 5-7 years. And if you look at 25 years, it will certainly be 10-12 times”, he said.
Fortune India is now on WhatsApp! Get the latest updates from the world of business and economy delivered straight to your phone. Subscribe now.